Hi Brahms,
You are correct they are treated as a cost to the business as they are given to parties as compensation. The Black Scholes model is a standard method of valuation of these options and though there is no cash cost to the business, they book an expense and also book a capital reserve (see page 7 of the report) that effectively sum to zero in the capital account. Sorry probably lost most sane people a while back, unfortunately I had to account for these in a previous life.
You are also correct that the consultant options confer a right to buy 1,750,000 shares at $0.50 per share on or before the 14th of November 2021. There are 2 tranches of directors options of 400,000 each that Terry Sweet (200,000), Ian Roger Moore (100,000) and Paul House (100,000) are entitled to exercisable at $0.50 and $0.67 each. Right now these options are out of the money and the consultants are not even entitled to their options until the shares trade above $0.45 per share for 20 days. The consultants would have to pay $875,000 to exercise all their options and the directors would have to pay $200,000 for the 50c options and $268,000 for the 67c options. Total of $1,343,000 in cash to be collected by the company before the shares are issued.
I hope that adds a minuscule amount of light to a not very clear accounting way of dealing with a real world issue.
- Forums
- ASX - By Stock
- Ann: Appendix 4D and Interim Financial Report
PIQ
proteomics international laboratories ltd
Add to My Watchlist
4.92%
!
29.0¢

Hi Brahms,You are correct they are treated as a cost to the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
29.0¢ |
Change
-0.015(4.92%) |
Mkt cap ! $47.42M |
Open | High | Low | Value | Volume |
30.0¢ | 31.0¢ | 28.5¢ | $191.2K | 643.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 53694 | 29.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 51000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 53694 | 0.295 |
5 | 47282 | 0.280 |
3 | 141892 | 0.275 |
1 | 25000 | 0.270 |
1 | 10000 | 0.260 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 51000 | 2 |
0.330 | 2000 | 1 |
0.345 | 1260 | 1 |
0.350 | 50000 | 1 |
0.355 | 2498 | 1 |
Last trade - 15.36pm 26/06/2025 (20 minute delay) ? |
Featured News
PIQ (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online